Status:
UNKNOWN
Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
Lead Sponsor:
University Hospital, Angers
Collaborating Sponsors:
Novo Nordisk A/S
Conditions:
Growth Hormone Deficiency
Eligibility:
All Genders
18-35 years
Brief Summary
Hypopituitary adults with all the hormonal deficiencies are well subsituted excepted for the growth hormone (GH) and died earlier than the rest of the population. GH deficiency involves a fat mass inc...
Eligibility Criteria
Inclusion
- Adults (age \> 18-35 years)
- Stable body mass +/- 5 kg in 3 months
- GH deficiency since childhood, treated by GH during childhood, having stopped GH treatment at the end of adolescence
- Want to receive again GH treatment or refusing new GH treatment
- GH deficiency confirmed at adulthood by GHRH-Arginine test
- Women receiving GH treatment must have a efficient contraceptive method
- Have given a writing informed consent
Exclusion
- Somatotropic insufficiency
- All pathologies or treatment modifing energetic metabolism, excepted diabet mellitus and obesity
- Participating to another clinical trial during the three months befor inclusion
- Pathologies modifing bone metabolism
- Pregnancy/Feeding
- Refusal to consent
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
End Date :
August 1 2005
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00187993
Start Date
May 1 2005
End Date
August 1 2005
Last Update
September 16 2005
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
UH of Angers
Angers, France, 49000
2
UH of Brest
Brest, France
3
UH of Caen
Caen, France
4
UH of Limoges
Limoges, France